SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-7.2%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$310M
AUM Growth
+$310M
(-16%)
Cap. Flow
-$32.1M
Cap. Flow
% of AUM
-10.36%
Top 10 Holdings %
Top 10 Hldgs %
50.58%
Holding
85
New
10
Increased
22
Reduced
16
Closed
22
Top Buys
| 1 |
Galapagos
GLPG
|
$11.8M |
| 2 |
Cigna
CI
|
$10.2M |
| 3 |
Merck
MRK
|
$9.39M |
| 4 |
Cardinal Health
CAH
|
$5.32M |
| 5 |
RCOR
Renovacor, Inc.
RCOR
|
$4.85M |
Top Sells
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$8.71M |
| 2 |
Amgen
AMGN
|
$8.53M |
| 3 |
AFMD
Affimed
AFMD
|
$6.07M |
| 4 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$5.72M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$5.6M |
Sector Composition
| 1 | Healthcare | 89.71% |
| 2 | Consumer Staples | 2.95% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cigna
CI
$80.3B
| $27.7M | 8.82% | 138,224 +51,032 | +59% | +$10.2M |
|
2
Curis
CRIS
$20.9M
| $22.8M | 7.27% | 2,914,127 -450,278 | -13% | -$3.53M |
|
3
SPDR Gold Trust
GLD
$107B
| $16.8M | 5.37% | 102,553 +7,123 | +7% | +$1.17M |
|
|
SOLY
4
DELISTED
Soliton, Inc.
SOLY
| $16.8M | 5.35% | 824,803 | – | – |
|
5
Universal Health Services
UHS
$11.6B
| $14M | 4.46% | 101,051 +27,916 | +38% | +$3.86M |
|
6
HCA Healthcare
HCA
$94.5B
| $13.7M | 4.36% | 56,409 -9,164 | -14% | -$2.22M |
|
|
7
Galapagos
GLPG
$2.07B
| $11.8M | 3.77% | +224,719 | New | +$11.8M |
|
8
Aveanna Healthcare
AVAH
$1.67B
| $11.2M | 3.57% | 1,397,272 +195,665 | +16% | +$1.57M |
|
9
Centene
CNC
$14.3B
| $11.2M | 3.56% | 179,232 +23,616 | +15% | +$1.47M |
|
10
United Therapeutics
UTHR
$13.8B
| $10.9M | 3.48% | 59,146 +12,434 | +27% | +$2.3M |
|
|
11
Merck
MRK
$210B
| $9.39M | 2.99% | +125,000 | New | +$9.39M |
|
12
Herbalife
HLF
$1.01B
| $9.16M | 2.92% | 216,012 +61,174 | +40% | +$2.59M |
|
13
McKesson
MCK
$85.4B
| $8.73M | 2.78% | 43,797 -5,827 | -12% | -$1.16M |
|
|
14
Cardinal Health
CAH
$35.5B
| $7M | 2.23% | 141,423 +107,605 | +318% | +$5.32M |
|
|
RCOR
15
DELISTED
Renovacor, Inc.
RCOR
| $6.66M | 2.12% | 736,323 +536,323 | +268% | +$4.85M |
|
|
ALBO
16
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $6.66M | 2.12% | 213,493 -52,123 | -20% | -$1.63M |
|
17
Mirum Pharmaceuticals
MIRM
$3.71B
| $4.96M | 1.58% | 248,978 -205,914 | -45% | -$4.1M |
|
18
Integer Holdings
ITGR
$3.78B
| $4.9M | 1.56% | 54,891 -11,937 | -18% | -$1.07M |
|
19
HealthEquity
HQY
$7.72B
| $4.76M | 1.52% | 73,458 +8,500 | +13% | +$550K |
|
20
Vertex Pharmaceuticals
VRTX
$100B
| $4.63M | 1.47% | 25,500 +1,600 | +7% | +$290K |
|
21
Gilead Sciences
GILD
$140B
| $4.58M | 1.46% | +65,500 | New | +$4.58M |
|
22
Kura Oncology
KURA
$686M
| $4.28M | 1.36% | 228,318 +6,055 | +3% | +$113K |
|
23
X4 Pharmaceuticals
XFOR
$84.2M
| $4.26M | 1.36% | 804,597 | – | – |
|
24
Cross Country Healthcare
CCRN
$438M
| $4.24M | 1.35% | 199,460 -80,390 | -29% | -$1.71M |
|
25
Viking Therapeutics
VKTX
$3.04B
| $4.15M | 1.32% | 660,813 +41,033 | +7% | +$258K |
|